share_log

デ・ウエスタン・セラピテクス研究所:眼科手術補助剤「DW-1002」とトリパンブルーの配合剤の米国開発決定並びに米国FDAオーファンドラッグ指定のお知らせ

D. Western Therapeutics Institute: Notice of US development decision and US FDA orphan drug designation for a combination of the ophthalmic surgery aid “DW-1002” and trypan blue

JPX ·  Jul 23, 2023 19:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more